SYRE·00773J202·US·equity·Healthcare - Biotechnology-Activist
SYRE (SPYRE THERAPEUTICS INC) is held by 109 institutional investors as of Q1 2026. Largest holders: FMR LLC ($594.2M), BlackRock, Inc. ($278.5M), RTW INVESTMENTS, LP ($210.4M). Net institutional sentiment: Bullish.
See how SYRE's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer